Noubar Afeyan, Ph.D., Founder and CEO, Flagship Pioneering
Houman Ashrafian, D.Phil., Managing Partner, SV Health Investors
Bruce Booth, D.Phil., Partner, Atlas Venture
Mark Currie, Ph.D., President and CSO, Cyclerion Therapeutics Inc.
Francis Cuss, M.D., (former) EVP and CSO, R&D, Bristol-Myers Squibb Co.
Francesco de Rubertis, Ph.D., Co-founder and Partner, Medicxi
Susan Dillon, Ph.D., Co-Founder, President and CEO of Aro Biotherapeutics Co.
Todd Foley, Managing Director, MPM Capital
Carol Gallagher, Pharm.D., Partner, New Enterprise Associates
Laurie Glimcher, M.D., President and CEO, Dana-Farber Cancer Institute
Michael Hayden, M.D., Ph.D., (former) President Global R&D, CSO, Teva Pharmaceutical Industries Ltd.
Kewen Jin, M.D., Managing Partner, Serica Partners
Sophie Kornowski, Ph.D., Senior Partner, Gurnet Point Capital
Iya Khalil, Ph.D., Chief Commercial Officer and Co-Founder, GNS Healthcare Inc.
Reid Huber, Ph.D., Partner, Third Rock Ventures
Menelas Pangalos, Ph.D., EVP, BioPharmaceuticals R&D, AstraZeneca plc
Antoine Papiernik, Managing Partner, Sofinnova Partners
Kush Parmar, M.D., Ph.D., Managing Partner, 5AM Ventures
Cary Pfeffer, M.D., Partner, Third Rock Ventures
Andrew Plump, M.D., Ph.D., President of R&D, Takeda Pharmaceutical Co. Ltd.
Otello Stampacchia, Ph.D., Founder and Managing Director, Omega Funds
Paul-Peter Tak, M.D., Ph.D., Venture Partner, Flagship Pioneering, CEO, Kintai Therapeutics Inc.
Helen Tayton-Martin, Ph.D., CBO, Adaptimmune Ltd.
James Sabry, M.D., Ph.D., Global Head of Pharma Partnering, Roche
Marc Tessier-Lavigne, Ph.D., President, Stanford University
Jan van de Winkel, Ph.D., President and CEO, Genmab A/S
Keith Yamamoto, Ph.D., Vice Chancellor, Science Policy and Strategy, University of California San Francisco
Douglas Williams, Ph.D., Co-founder, President and CEO, Codiak BioSciences Inc.
Elias Zerhouni, M.D., (former) President, Global R&D, Sanofi
